GoalVest Advisory’s Organon & Co OGN Stock Holding History

GoalVest Advisory’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-965	Closed	-$6.92K	–	521
2025 Q4	$6.92K	Buy	+965	New	+$7.62K	﹤0.01%	449
2022 Q3	–	Sell	-14	Closed	–	–	292
2022 Q2	$0	Hold	14	–	–	﹤0.01%	474
2022 Q1	$0	Buy	+14	New	+$479	﹤0.01%	468
2021 Q2	$1K	Buy	+36	New	+$1.19K	﹤0.01%	235

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

GoalVest Advisory's OGN Position: Q1 2026 in Review

GoalVest Advisory sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 965 shares — an estimated $6.92K sold.

GoalVest Advisory first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $6.92K in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

GoalVest Advisory reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
GoalVest Advisory sold 965 Organon & Co shares in Q1 2026, an estimated $6.92K.
GoalVest Advisory first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
GoalVest Advisory's Organon & Co position peaked at $6.92K in Q4 2025.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on GoalVest Advisory's 13F filing for Q1 2026, filed 13 Apr 2026.